Designating itself previously as “pretty much now the only remaining vertically-integrated antibiotic manufacturer left in the western world,” Sandoz has announced plans to invest further at its manufacturing facility in Kundl, Austria, bringing total investment in the Sandoz antibiotics network across Europe to more than a quarter-of-a-billion euros.
The Novartis division will inject an additional €50m ($49.9m) at Kundl to support increased European manufacturing capacity for finished dosage...






